PNC Financial Services Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.5K | Buy |
|
|||||
|
2025
Q1 | $10.3K | Buy |
|
|||||
|
2024
Q4 | $8.2K | Sell |
|
|||||
|
2024
Q3 | $15.3K | Sell |
|
|||||
|
2024
Q2 | $26.8K | Sell |
|
|||||
|
2024
Q1 | $30.3K | Buy |
|
|||||
|
2023
Q4 | $38.3K | Sell |
|
|||||
|
2023
Q3 | $44.4K | Sell |
|
|||||
|
2023
Q2 | $56.6K | Buy |
|
|||||
|
2023
Q1 | $60.4K | Sell |
|
|||||
|
2022
Q4 | $52.6K | Sell |
|
|||||
|
2022
Q3 | $64K | Buy |
|
|||||
|
2022
Q2 | $32K | Sell |
|
|||||
|
2022
Q1 | $73K | Buy |
|
|||||
|
2021
Q4 | $53K | Sell |
|
|||||
|
2021
Q3 | $179K | Sell |
|
|||||
|
2021
Q2 | $315K | Sell |
|
|||||
|
2021
Q1 | $393K | Sell |
|
|||||
|
2020
Q4 | $588K | Buy |
|
|||||
|
2020
Q3 | $309K | Sell |
|
|||||
|
2020
Q2 | $322K | Buy |
|
|||||
|
2020
Q1 | $18K | Buy |
|
|||||
|
2019
Q4 | $19K | Sell |
|
|||||
|
2019
Q3 | $20K | Buy |
|